Your browser is old and is not supported. Upgrade for better security.

Invest in Gerostate Alpha (YC S18)

A pharmaceutical company dedicated to treating aging and age-related disease

Highlights

1
πŸ’΅ $2.1M raised in initial seed round, at $15M valuation
2
🧬 Team at the forefront of aging research for decades, collectively authoring 200+ papers
3
πŸ’ͺ Our platform delivers drug candidates to slow aging at a success rate of 20%
4
🐭 Funds will be used to test 10-15 of our hits in aging mice
5
🧳 Executive chairman was former CEO of major pharma company, Sangamo Therapeutics

Our Team

We know how to stop the threat of chronic disease; and we care because aging is 100% fatal

Pitch

πŸ”— Link to recorded Clubhouse pitch night on Startup Club


Downloads

Overview